搜索
Avidity Biosciences Inc
RNA添加自选
12.660USD
+0.180+1.44%
收盘 06/18, 16:00（美东）报价延迟15分钟
216.56M总市值
亏损市盈率 TTM
股东统计
更新时间: 5月14日 周四
更新时间: 5月14日 周四
持股股东
股东类型
持股股东
持股股东
占比
T. Rowe Price Associates, Inc.
9.08%
The Vanguard Group, Inc.
5.71%
Vanguard Capital Management, LLC
3.66%
BlackRock Institutional Trust Company, N.A.
2.48%
Vanguard Portfolio Management, LLC
2.01%
其他
77.06%
持股股东
持股股东
占比
T. Rowe Price Associates, Inc.
9.08%
The Vanguard Group, Inc.
5.71%
Vanguard Capital Management, LLC
3.66%
BlackRock Institutional Trust Company, N.A.
2.48%
Vanguard Portfolio Management, LLC
2.01%
其他
77.06%
股东类型
持股股东
占比
Investment Advisor
25.83%
Individual Investor
4.27%
Investment Advisor/Hedge Fund
3.09%
Bank and Trust
0.13%
Pension Fund
0.05%
Insurance Company
0.02%
Research Firm
0.02%
其他
66.59%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
102
4.97M
29.04%
+3.65M
2025Q4
583
152.91M
98.84%
-7.85M
2025Q3
513
144.57M
99.88%
-1.36M
2025Q2
498
141.72M
117.38%
-3.41M
2025Q1
508
142.16M
117.97%
-7.67M
2024Q4
492
135.01M
112.33%
-12.86M
2024Q3
467
132.62M
112.76%
+3.34M
2024Q2
414
118.94M
111.18%
+14.23M
2024Q1
365
96.48M
102.78%
+1.47M
2023Q4
345
83.09M
112.13%
-13.56M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
772.23K
4.51%
+772.23K
--
Feb 28, 2026
BlackRock Institutional Trust Company, N.A.
8.76K
0.05%
+8.76K
--
Feb 28, 2026
Boyce (Sarah)
265.09K
1.55%
+265.09K
--
Feb 26, 2026
Gallagher (Kathleen P)
28.86K
0.17%
+28.86K
--
Feb 26, 2026
Charles Schwab Investment Management, Inc.
33.70K
0.2%
+33.70K
--
Feb 28, 2026
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Return Stacked Bonds & Merger Arbitrage ETF
11.96%
Global X Genomics & Biotechnology ETF
7.84%
ALPS Medical Breakthroughs ETF
4.27%
State Street SPDR S&P Biotech ETF
3.4%
ProShares Merger ETF
2.74%
Direxion Daily S&P Biotech Bull 3X Shares
1.82%
Virtus LifeSci Biotech Clinical Trials ETF
1.47%
AltShares Event-Driven ETF
1.46%
ProShares Ultra Nasdaq Biotechnology
1.12%
Invesco Nasdaq Biotechnology ETF
0.87%
查看更多
Return Stacked Bonds & Merger Arbitrage ETF
占比11.96%
Global X Genomics & Biotechnology ETF
占比7.84%
ALPS Medical Breakthroughs ETF
占比4.27%
State Street SPDR S&P Biotech ETF
占比3.4%
ProShares Merger ETF
占比2.74%
Direxion Daily S&P Biotech Bull 3X Shares
占比1.82%
Virtus LifeSci Biotech Clinical Trials ETF
占比1.47%
AltShares Event-Driven ETF
占比1.46%
ProShares Ultra Nasdaq Biotechnology
占比1.12%
Invesco Nasdaq Biotechnology ETF
占比0.87%
